Volver a Agenda
Session Chair(s)
Sue-Jane Wang, PHD, MA, MS
Mathematician Statistician
FDA, United States
Learning Objective : Describe biomarker developments for their potential in enhancing drug development; Describe global planning of clinical development programs from preclinical study through clinical development; Explain biomarker uses in medical product development.
Speaker(s)
From Animal to Man: Challenges of Biomarkers in Alzheimer's Research
Tom Jacobs, PHD
Janssen R&D, Belgium
Principal Statistician
Trends in Trial Durations and Underlying Drivers on Biomarkers in Oncology
Christine Blazynski, PHD
Citeline, Inc., United States
Chief Science Officer and Senior Vice President
Challenges to Oncology Biomarker Development and Clinical Utility: An Industry Perspective
William L. Trepicchio, PHD, MSC
Takeda Pharmaceuticals International, Inc., United States
Senior Director of Translational Medicine
¿Tiene una cuenta?